1.
Int J Infect Dis
; 91: 101-103, 2020 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31759170
RESUMO
We describe a symptomatic Plasmodium falciparum infection in a 29-year-old Guinean man receiving Infliximab for one year and without recent travel. The reactivation of submicroscopic malaria following the inhibition of TNF-alpha by infliximab is suspected.